Clinical Trials Directory

Trials / Completed

CompletedNCT04239222

Feasibility Study to Evaluate a New Energy Storage and Return Prosthetic Foot

Prospective, Feasibility Study to Evaluate Performance, Patient Benefits, and Acceptance of a New Energy Storage and Return Prosthetic Foot

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Otto Bock Healthcare Products GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, interventional, multicenter pilot study to characterize differences in performance and patient reported outcomes between the Taleo, Proflex XC, and the new Revo prosthetic foot.

Detailed description

The purpose of the Revo-M Study is to characterize differences in performance and patient reported outcomes between the Revo investigational prosthetic foot and a comparative prosthetic foot (Taleo or Proflex XC) when compared to the control foot which is the subject's currently used energy storage and return (ESR) prosthetic foot. The data obtained from this study may also serve to determine the long-term performance of Revo.

Conditions

Interventions

TypeNameDescription
DEVICERevo-MInvestigational energy storage and return prosthetic foot with using novel elastic elements.
DEVICETaleoCommercially available carbon-fiber energy storage and return foot used as comparative foot for transfemoral amputee subjects
DEVICEProflex XCCommercially available carbon-fiber energy storage and return foot used as comparative foot for transtibial amputee subjects

Timeline

Start date
2020-03-10
Primary completion
2022-03-11
Completion
2022-03-11
First posted
2020-01-27
Last updated
2024-09-23
Results posted
2024-09-23

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04239222. Inclusion in this directory is not an endorsement.